Incyte
INCY
113.44
+0.71
+0.63%
Incyte
US · INCY
#803 by market cap
Listed 1970
113.44
+0.71
+0.63%
Live - 5344 symbols - heartbeat 318s ago
· 2026-10-08 07:00
Pre-market
112.86
-0.51%
After-hours
111.97
-1.30%
Overnight
113.45
+0.01%
- Market cap
- 22.99B
- P/E (TTM)i
- 14.45
- P/Bi
- 3.62
- EPSi
- 6.41
- Div yieldi
- 0.00%
- 52W posi
- 62%
Reader sentiment
Are you bullish or bearish on INCY?
Anonymous reader poll. Unscientific, not investment advice.
About Incyte
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.
- Founded
- 1991
- CEO
- Mr. William Meury
- Employees
- 2,844
- Headquarters
- Wilmington, Delaware, United States of America
- Fiscal year end
- 12-31
- Website
- incyte.com
Company profile
- Exchange
- US
- Symbol
- INCY
- Market-cap rank
- #803
- Listing date
- 1970-01-01
- Market cap
- 22.99B
- Float cap
- 19.33B
- Shares out
- 202.70M
- Float shares
- 170.41M
Sectors & themes
Biotechnology
CAR-T Therapy
ARK Portfolio
Global medical industry
Regular Savings Plan
Fractional Shares JP
Quote time 2026-10-08 07:00:03 · For reference only, not investment advice and not tailored to your situation.